In a study published in Science Daily, cholesterol-lowering drug and its link to sleep disruptions was investigated.
The study noted: “A cholesterol-lowering drug appears to disrupt sleep patterns of some patients, researchers reported at the American Heart Association’s Scientific Sessions 2007.”
In the study, researchers tested 1,016 healthy adult men and women for six months in a randomized, double-blind, placebo-controlled trial using simvastatin, given at 20 milligrams (mg), pravastatin at 40 mg, or a placebo.
They assessed outcomes with the Leeds sleep scale, a visual analogy scale of sleep quality, and a rating scale of sleep problems. Both scales were measured before and during treatment.
Published at Wed, 16 Jun 2021 17:58:51 +0000